DELIVER and DAPA-HF Pooled Analysis in Brief
Published: 29 August 2022
In this video, Prof Carolyn Lam (National Heart Centre Singapore, SG) and Prof John McMurray (University of Glasgow, UK) put into context the pooled analysis of DELIVER and DAPA-HF and consider whether these results can be applied across the spectrum of EF in Heart Failure, addressing the suitability of patients according to their individual ejection fraction.
Recorded at ESC Congress 2022, Barcelona.
To find out more, listen to Prof Lam and Prof McMurray discuss the DELIVER Trial in Brief.
Key Learning Objectives
Following the completion of this programme, physicians should be in a position to:
- Recall the clinical relevance of the pooled DELIVER and DAPA-HF trial results
- Identify patients from across the LVEF range who are likely to benefit from an SGLT-2 inhibitor
- Heart Failure Specialists
- General Cardiologists
- Allied Healthcare Professionals
More from this programme
Professor and Senior Consultant
Prof Carolyn Lam is a Senior Consultant at the Department of Cardiology and Director of Women's Heart Health at the National Heart Centre Singapore, having pioneered the first Women’s Heart Clinic in Singapore. Prof Lam is a world-renowned specialist in heart failure (particularly heart failure with preserved ejection fraction [HFpEF]). Her work in the PARAGON-HF and EMPEROR-Preserved trials led to the first FDA-approved treatment for HFpEF and the first robustly positive clinical outcomes trial in HFpEF to-date.
John JV McMurray
Professor of Cardiology
Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.
Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.